Skip to content

Chronic Mycoprotein Consumption and Nucleotide Content in Metabolic Health

Effect of Chronic Mycoprotein Consumption, and of Its Nucleotide Content, in Uric Acid Concentrations and Other Markers of Metabolic Health in Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02984358
Acronym
MYTH
Enrollment
30
Registered
2016-12-06
Start date
2017-01-31
Completion date
2017-12-31
Last updated
2018-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

Compare chronic (one week) of a 'normal' meat diet with one week of mycoprotein consumption, with or without a reduced nucleotide content, on markers of metabolic health, such as uric acid concentrations, blood glucose control and blood lipid profiles.

Interventions

OTHERAnimal protein based diet
OTHERLow-nucleotide mycoprotein based diet
OTHERHigh-nucleotide mycoprotein based diet

Sponsors

University of Exeter
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI between 18 and 30

Exclusion criteria

* On medication (except contraception) * Smokers * Diagnosed with any metabolic or cardiovascular conditions * BMI \< 18 or \> 30 * Dietary restrictions (vegetarians/vegans, etc.)

Design outcomes

Primary

MeasureTime frame
Serum uric acid concentrationsMeasured at baseline; days 2, 4 and 6 of the intervention; and after the 1 week intervention (day 8)

Secondary

MeasureTime frame
24 h blood glucose homeostasis - measured using a Dexcom CGMSMeasured 5 days at baseline (habitual data) and 5 days during the intervention (days 3 - 7)
Metabolomics (using Nuclear Magnetic Resonance - NMR)Measured at baseline; days 2, 4 and 6 of the intervention; and after the 1 week intervention (day 8)
Glycaemia and serum insulin - insulin sensitivity (oral glucose tolerance test)Measured at baseline and after 1 week intervention (day 8)
IL-6Measured at baseline and after 1 week intervention (day 8)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026